Form 4 · ABBV
AbbVie EVP Jeffrey Ryan Stewart reports selling 40,619 shares
Jeffrey Ryan Stewart, AbbVie's EVP, CHIEF COMMERCIAL OFFICER, filed a Form 4 on Nov 12, 2026 at 5:00 PM ET reporting transactions between Nov 9, 2026 and Nov 12, 2026.
The filing reports 40,619 shares in an open-market or private sale (code S) at $293.60, about $11.9 million in total; 40,619 shares in an exercise or conversion of a derivative security (code M); and 3,450 shares given as a gift (code G).
The filing does not indicate that the sales were made under a Rule 10b5-1 trading plan.
After these transactions, the filing lists 79,721 shares of Common Stock, $0.01 par value held directly.
Effect on holdings
Taken together, the rows reported here lowered Jeffrey Ryan Stewart's directly held shares by 4.1%, from 83,171 to 79,721.
Reporting person
- Jeffrey Ryan Stewart, EVP, CHIEF COMMERCIAL OFFICER (as filed: Stewart Jeffrey Ryan)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-09 | M | Common Stock, $0.01 par value | 16,070 | $114.36 | Acquired | 99,241 | Direct |
| 2026-11-09 | M | Common Stock, $0.01 par value | 24,549 | $93.50 | Acquired | 123,790 | Direct |
| 2026-11-09 | S | Common Stock, $0.01 par value | 40,619 | $293.60 | Disposed | 83,171 | Direct |
| 2026-11-12 | G | Common Stock, $0.01 par value | 3,450 | Disposed | 79,721 | Direct | |
| 2026-11-09 | M | Option (Right to Buy) (derivative) | 16,070 | Disposed | 0 | Direct | |
| 2026-11-09 | M | Option (Right to Buy) (derivative) | 24,549 | Disposed | 24,550 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 12, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
AbbVie company file → · More AbbVie filings
Disclosures
- Editor holdings in ABBV
- The editor holds no position in AbbVie (ABBV). As of Nov 11, 2026.
- Last updated
- Nov 12, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.